Olivier Brandicourt to leave Bayer HealthCare

Werner Baumann (left) and Olivier Brandicourt

Effective March 31, 2015, Oliver Brandicourt, Chairman of the Board of Management of Bayer Healthcare AG and member of the Executive Council of Bayer AG, will leave the company to become the new CEO of Sanofi. On the same date, Werner Baumann, member of the Board of Management of Bayer AG, will take over the function of Chairman at Bayer HealthCare. 

Baumann will remain a member of the Board of Management of Bayer AG and of the company's Executive Council. He will also retain responsibility for strategy and portfolio management as well as for the Europe region. He already held leading positions at Bayer HealthCare from 2002 to 2009 – initially as Head of Central Administration & Organization and later as a member of the Board of Management and as the subgroup's Labor Director. Between 2006 and 2009, he actively participated in the integration of Schering AG, Berlin, Germany. Bayer HealthCare comprises the Pharmaceuticals, Consumer Care, Animal Health and Medical Care divisions.

"I would like to thank Olivier Brandicourt for his commitment and his contributions to the very successful development of Bayer HealthCare and I wish him all the best in his new function as CEO of Sanofi," said Dr. Marijn Dekkers, Chairman of the Board of Management of Bayer AG. "At the same time, I am very pleased that Werner Baumann will be leading our HealthCare business. He is a highly experienced leader with extensive expertise in this area." Over the coming months, Baumann will steer HealthCare's operating business together with the HealthCare Executive Committee and will work on the strategic realignment of the business in light of Bayer's future concentration on the Life Sciences HealthCare and CropScience as announced. 

READ THE NEWS RELEASE